Research ArticleOriginal Article
Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer
Rongna Ma, Nannan Feng, Xiao Yu, Hongyan Lin, Xiaohong Zhang, Oumin Shi, Huan Zhang, Shuo Zhang, Lei Li, Min Zheng, Ming Gao, Herbert Yu and Biyun Qian
Cancer Biology & Medicine November 2017, 14 (4) 377-386; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0061
Rongna Ma
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Nannan Feng
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Xiao Yu
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Hongyan Lin
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Xiaohong Zhang
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Oumin Shi
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Huan Zhang
2Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
Shuo Zhang
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Lei Li
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Min Zheng
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Ming Gao
2Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
Herbert Yu
3Cancer Epidemiology Program, University of Hawaii Cancer Center, HI 96813, USA
Biyun Qian
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
References
- 1.↵Globocan 2012: Estimated Cancer Incidence. Mortality and Prevalence Worldwide in 2012. 2013. Available at http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx Accessed May 2017.
- 2.↵
- 3.↵
- Stewart DJ.
- 4.↵
- Doerfler W.
- 5.
- Busslinger M,
- Hurst J,
- Flavell RA.
- 6.↵
- Sepulveda H,
- Villagra A,
- Montecino M.
- 7.↵
- Rhee JK,
- Kim K,
- Chae H,
- Evans J,
- Yan P,
- Zhang BT, et al.
- 8.↵
- Yu YP,
- Ding Y,
- Chen R,
- Liao SG,
- Ren BG,
- Michalopoulos A, et al.
- 9.↵
- Li J,
- Ching T,
- Huang S,
- Garmire LX.
- 10.↵
- Licchesi JDF,
- Westra WH,
- Hooker CM,
- Machida EO,
- Baylin SB,
- Herman JG.
- 11.
- Kobayashi K,
- Ouchida M,
- Tsuji T,
- Hanafusa H,
- Miyazaki M,
- Namba M, et al.
- 12.↵
- Zhang YW,
- Miao YF,
- Yi J,
- Geng J,
- Wang R,
- Chen LB.
- 13.↵
- Mazieres J,
- He B,
- You L,
- Xu ZD,
- Lee AY,
- Mikami I, et al.
- 14.↵
- Zhang XP,
- Yu XM,
- Jiang GY,
- Miao Y,
- Wang L,
- Zhang Y, et al.
- 15.↵
- Palpant NJ,
- Pabon L,
- Rabinowitz JS,
- Hadland BK,
- Stoick-Cooper CL,
- Paige SL, et al.
- 16.↵
- 17.↵
- Feng NN,
- Ching T,
- Wang Y,
- Liu B,
- Lin HY,
- Shi OM, et al.
- 18.↵
- Lee HJ,
- Finkelstein D,
- Li XF,
- Wu DQ,
- Shi DL,
- Zheng JJ.
- 19.↵
- Herman JG,
- Baylin SB.
- 20.↵
- Egger G,
- Liang GN,
- Aparicio A,
- Jones PA.
- 21.↵
- Esteller M,
- Gaidano G,
- Goodman SN,
- Zagonel V,
- Capello D,
- Botto B, et al.
- 22.↵
- Yu J,
- Tao Q,
- Cheng YY,
- Lee KY,
- Ng SSM,
- Cheung KF, et al.
- 23.↵
- Veeck J,
- Niederacher D,
- An H,
- Klopocki E,
- Wiesmann F,
- Betz B, et al.
- 24.↵
- Chen JJ,
- Wang AQ,
- Chen QQ.
- 25.↵
- Tariq K,
- Ghias K.
- 26.↵
- Lee SM,
- Park JY,
- Kim DS.
- 27.↵
- 28.↵
- Mullapudi N,
- Ye B,
- Suzuki M,
- Fazzari M,
- Han WG,
- Shi MK, et al.
- 29.↵
- Lin SY,
- Xia WY,
- Wang JC,
- Kwong KY,
- Spohn B,
- Wen Y, et al.
- 30.↵
- Cai SP,
- Cheng XY,
- Chen PJ,
- Pan XY,
- Xu T,
- Huang C, et al.
- 31.↵
- Suzuki M,
- Wada H,
- Yoshino M,
- Tian L,
- Shigematsu H,
- Suzuki H, et al.
- 32.↵
- 33.↵
- Suzuki M,
- Shigematsu H,
- Nakajima T,
- Kubo R,
- Motohashi S,
- Sekine Y, et al.
- 34.↵
- Jang JS,
- Jeon HS,
- Sun ZF,
- Aubry MC,
- Tang H,
- Park CH, et al.
In this issue
Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer
Rongna Ma, Nannan Feng, Xiao Yu, Hongyan Lin, Xiaohong Zhang, Oumin Shi, Huan Zhang, Shuo Zhang, Lei Li, Min Zheng, Ming Gao, Herbert Yu, Biyun Qian
Cancer Biology & Medicine Nov 2017, 14 (4) 377-386; DOI: 10.20892/j.issn.2095-3941.2017.0061
Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer
Rongna Ma, Nannan Feng, Xiao Yu, Hongyan Lin, Xiaohong Zhang, Oumin Shi, Huan Zhang, Shuo Zhang, Lei Li, Min Zheng, Ming Gao, Herbert Yu, Biyun Qian
Cancer Biology & Medicine Nov 2017, 14 (4) 377-386; DOI: 10.20892/j.issn.2095-3941.2017.0061
Jump to section
Related Articles
- No related articles found.